WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Ripon Sarkar
PeerJ Editor
400 Points

Contributions by role

Editor 400

Contributions by subject area

Cardiology
Nephrology
Radiology and Medical Imaging
Immunology
Biochemistry
Biodiversity
Pharmacology
Geriatrics
Data Science

Ripon Sarkar

PeerJ Editor

Summary

Ripon Sarkar is a dedicated researcher with over a decade of experience in cutting-edge technology in the fields of mitochondrial metabolism, cardiovascular disease, cancer biology and tissue engineering. Dr. Sarkar has demonstrated a profound commitment to advancing scientific knowledge and innovation.
Currently serving as a Postdoctoral Research Fellow at The UTHealth at Houston, Dr. Sarkar's research focuses on cardiovascular disease, especially on aortic and coronary artery disease to understand the molecular mechanism. His proficiency in these areas has been instrumental in conducting groundbreaking research and publishing his findings in reputable scientific journals. Throughout his academic and professional journey, Dr. Sarkar has been recognized with numerous honors and awards.
Dr. Sarkar's dedication to advancing scientific knowledge is further evidenced by his service to the community and his editorial contributions to various scientific journals. He is committed to leveraging his expertise to address pressing healthcare challenges and make meaningful contributions to society.

Cardiology Metabolic Sciences Molecular Biology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Work details

Postdoctoral Research Fellow

University of Texas Health Center at Houston
January 2023
Anesthesiology

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 3

Academic Editor on

March 31, 2025
Chaetoglobosin A induces apoptosis in T-24 human bladder cancer cells through oxidative stress and MAPK/PI3K-AKT-mTOR pathway
Jia Song, Jinyu Qiao, Mingxue Chen, Jiahui Li, Jixia Wang, Dayong Yu, Huachuan Zheng, Liying Shi
https://doi.org/10.7717/peerj.19085 PubMed 40183046
October 8, 2024
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome
Yinsheng Tan, Mingde Ren, Jie Hou, Tao Hou, Xianhe Lin
https://doi.org/10.7717/peerj.18154 PubMed 39399429
August 2, 2024
Prognostic value of left ventricular structure and strain in chronic kidney disease patients by cardiovascular magnetic resonance imaging: a retrospective study
Wenju Zhang, Yi Zhong, Fang Zhong, Tianhui Zhang, Xinghua Zhu, Weixiong Fan
https://doi.org/10.7717/peerj.17853 PubMed 39104364